Factors Associated With Time To Targeted Therapy For Patients With Metastatic Lung Cancer With Driver Mutations.

Suwei Wang,Hu Huang,Elisabeth Scheufele,Yull Edwin Arriaga,Gretchen Purcell Jackson,Irene Dankwa-Mullan

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 0|浏览5

暂无评分

摘要

120Background: Targeted therapies are superior to chemotherapy in metastatic lung cancer with driver gene mutations. Delays in initiation of targeted therapies may result in faster symptom progress...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要